Singapore, Nov. 3 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Open-Label, Randomized Study to Evaluate Inobrodib in Combination with Poma... Read More
Singapore, Nov. 3 -- The Health Sciences Authority received information related to the study titled 'A Long-Term Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder for Treatment of ... Read More
Singapore, Nov. 3 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose-Escalation Study to E... Read More
Singapore, Nov. 3 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Open-Label, Pharmacokinetic Study of Lepodisiran Administered as a Single Subcutaneous D... Read More
Singapore, Nov. 3 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects with Moderately to Severe... Read More
Singapore, Nov. 3 -- The Health Sciences Authority received information related to the study titled 'Evaluating the Year-Round Immunogenicity of Standard-Dose Versus High-Dose Seasonal Influenza Vacci... Read More
Singapore, Nov. 3 -- The Health Sciences Authority received information related to the study titled 'Beamion LUNG-1: An open label, Phase I dose escalation trial, with dose confirmation and expansion,... Read More
Singapore, Nov. 3 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutamid... Read More
Singapore, Nov. 3 -- The Health Sciences Authority received information related to the study titled 'Tucatinib continuation protocol: an open label study for participants from tucatinib clinical studi... Read More
Singapore, Nov. 3 -- The Health Sciences Authority received information related to the study titled 'A PHASE III, MULTICENTER, DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY O... Read More